VOLITION AMERICA, INC. EMPLOYMENT AGREEMENT GROUP CHIEF COMMERCIAL OFFICEREmployment Agreement • March 22nd, 2021 • Volitionrx LTD • In vitro & in vivo diagnostic substances • Texas
This Agreement (“Agreement”) is entered into as of February 01, 2021 (the “Effective Date”) by and between Volition America, Inc., a Delaware corporation (“Company”) and Gael Forterre (“Employee”). The Company and Employee are sometimes referred to herein individually as a “Party” or collectively as the “Parties”.
Permanent employment contractVolitionrx LTD • March 22nd, 2021 • In vitro & in vivo diagnostic substances
SINGAPORE VOLITION PTE. LIMITED EMPLOYMENT AGREEMENT GROUP CHIEF FINANCIAL OFFICEREmployment Agreement • March 22nd, 2021 • Volitionrx LTD • In vitro & in vivo diagnostic substances
This Employment Agreement (“Agreement”) is dated January 27, 2021 (“Execution Date”) and is effective from February 01, 2021 (the “Effective Date”) by and between Singapore Volition Pte. Limited, a Singapore corporation (“Company”) and Terig Hughes (“Employee”). The Company and Employee are sometimes referred to herein individually as a “Party” or collectively as the “Parties.
CONSULTING SERVICES AGREEMENTConsulting Services Agreement • March 22nd, 2021 • Volitionrx LTD • In vitro & in vivo diagnostic substances
THIS CONSULTING AGREEMENT (the “Agreement”) is dated January 29, 2021 (“Execution Date”) and is effective from October 01, 2020 (the “Effective Date”) by and between by and between Volition Germany, GmbH, a company with its registered address at Friedemann Bach Strasse 95, 82166, Gräfelfing, Germany (the “Company”) and 3F Management SPRL, a company located at [***] (the “Consultant”).
